Back
Share

Cellular Oncology

Cellular Oncology is not currently indexed in Scopus, DOAJ. Published by IOS Press BV.

ISSN 1570-5870Verify ISSN ↗1875-8606Verify ISSN ↗

Publisher: IOS Press BV

Scopus · InactiveOpen Access
1
Indexed in
major index

Cost to publish: Checking DOAJ for article charges…

Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.

Is Cellular Oncology indexed in Scopus? No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2004–2010).

What is the impact factor of Cellular Oncology? Cellular Oncology has no Journal Impact Factor — JIF is published only for Web of Science SCIE and SSCI titles — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.

Is Cellular Oncology in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).

Is Cellular Oncology open access? Yes — it is an open-access journal, listed in DOAJ.

Impact & reach — open metrics via OpenAlex

76
h-index
4.3
2-yr mean citations
781
i10-index
1,324
works indexed
32,549
total citations
Papers published per year
01002002017: 54 papers5420172018: 51 papers5120182019: 71 papers7120192020: 84 papers8420202021: 76 papers7620212022: 111 papers11120222023: 147 papers14720232024: 124 papers12420242025: 105 papers10520252026: 156 papers so far1562026*

Cellular Oncology published 105 papers in 2025; its busiest recent year was 2023 with 147. 2026* is the year so far.

Main topics
Cancer Cells and MetastasisCancer, Hypoxia, and MetabolismFerroptosis and cancer prognosisCancer Immunotherapy and Biomarkers

h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-09-24.

Who publishes here — latest 100 articles, 2026

Author countriesChinaChina82.9%United StatesUnited States2.6%GermanyGermany2.5%TaiwanTaiwan1.5%Hong Kong SAR ChinaHong Kong SAR China1.5%PolandPoland1% Most frequent institutions (papers)Sun Yat-sen UniversitySun Yat-sen University9Shanghai Jiao Tong UniversityShanghai Jiao Tong University7Fudan UniversityFudan University6Zhongshan HospitalZhongshan Hospital6Fujian Medical UniversityFujian Medical University5

In its latest 100 research articles (2026), authors are most often from China (82.9%), United States (2.6%) and Germany (2.5%). More than half of recent authorship comes from one country. Countries are counted fractionally, so a paper by authors from two countries counts half to each.

Integrity signals — indicators, not proof of misconduct

  • Scopus statusInactive — coverage ended 2010
  • Retracted papers 16 · 12.1 per 1,000 papers
  • Author concentration82.9% of recent authorship from China

Retractions and authorship from OpenAlex; Scopus status from the Scopus source list. A signal marks something to look at more closely; it is not a finding against the journal.

Official sources & links

Scopus source ↗ DOAJ ↗ ISSN Portal · 1570-5870 ↗ISSN Portal · 1875-8606 ↗

Related journals

← Back to Journal Finder

Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.